ARCHIVES

Letter to the Editor

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System

August 26, 1977

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011